Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Sinovac completes dosing in phase 1 human clinical testing of SARS vaccine

Sinovac Biotech Ltd. has announced that all 36 subjects of the Phase I human clinical trial for its inactivated SARS vaccine have now been vaccinated with two doses of either SARS vaccine or placebo.

7 Sep 2004

New drug application for exenatide has been accepted for review

Amylin Pharmaceuticals and Eli Lilly today announced that the New Drug Application for exenatide has been accepted for review by the Food and Drug Administration.

2 Sep 2004

Ageing population and technological progress combine to drive European orthopaedic braces and supports market

By 2020, the elderly are expected to comprise almost a quarter of Europe's total population. This changing demography is set to underpin a rise in the incidence of age-related orthopaedic problems

31 Aug 2004

Call for increased political and financial commitment to the development of preventive and therapeutic AIDS vaccines

At the opening ceremony of the Lausanne, Switzerland, AIDS VACCINE '04 conference, leaders in the field of AIDS vaccine research called for increased political and financial commitment to facilitate the development of preventive and therapeutic AIDS vaccines as a public health imperative in fighting HIV/AIDS.

30 Aug 2004

High tech implants to aid facial reconstruction

Loughborough University researchers have been awarded more than £200,000 to develop state-of-the-art tailor made implants for people requiring facial reconstructive surgery.

27 Aug 2004

Chiron delays Fluvirin influenza virus vaccine shipments

Chiron has announced that, in conducting final internal release procedures for its Fluvirin(R) influenza virus vaccine, the company's quality systems have identified a small number of lots that do not meet product sterility specifications.

26 Aug 2004

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Human Genome Sciences has begun dosing patients in a Phase 1 clinical trial of HGS-TR2J, a novel agonistic human monoclonal antibody to TRAIL Receptor 2, in patients with advanced solid malignancies.

25 Aug 2004

Contract for the production of an investigational vaccine based on an H9N2 strain of avian influenza virus

In 1999 and 2003, an H9N2 influenza strain caused illness in three people in Hong Kong. Scientists are concerned about H9N2 and other emerging types of avian influenza viruses because as they spread—most commonly through poultry—they continually mutate, increasing chances that they may infect humans, evade the body’s immune response and become more lethal.

17 Aug 2004

Study on RNAi technology targeting neurodegenerative diseases

Sirna Therapeutics has announced the publication of preclinical studies evaluating RNA interference-based therapies for a class of inherited neurodegenerative diseases of the central nervous system (CNS) in the current issue of Nature Medicine.

16 Aug 2004

Dynamics between disposable and reusable segments affect expansion of disposable drapes and gowns markets

The market for disposable surgical drapes and gowns in Europe has seen steady growth in the recent past owing to the high standards of infection control enforced by the new European Union Medical Device Directive (MDD) and EU regulations.

11 Aug 2004

Genentech announces FDA approval of Avastin manufacturing

Genentech has announced that the U.S. Food and Drug Administration approved the supplemental Biologics License Application (sBLA) for the manufacturing of Avastin™ (bevacizumab) bulk drug substance at the company's facility in Vacaville, California.

11 Aug 2004

FDA asks Utah Medical Products to stop manufacturing and distributing medical devices

The U.S. Food and Drug Administration has announced that it is asking Utah Medical Products, to stop manufacturing and distributing medical devices until the firm has demonstrated that it has corrected deviations from Current Good Manufacturing Practice, as set forth in the Quality System regulation.

11 Aug 2004

Total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010

Poised on the brink of phenomenal growth, the oligonucleotides market offers a plethora of opportunities to the enterprising investor. Recent analysis by Frost & Sullivan estimates that the total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010.

9 Aug 2004

Illinoisans get legislation giving the state more regulatory authority over water bottling plants

In an effort to ensure that the bottled water that Illinoisans are drinking is safe, Gov. Rod R. Blagojevich today signed legislation giving the state more regulatory authority over water bottling plants and private water source operators.

6 Aug 2004

Promising new cancer drug, Nanotax

A Lawrence company that uses patented technology created at the University of Kansas to improve the effectiveness of drugs has won a $100,000 National Institutes of Health grant to support further testing of the company's promising new cancer drug, Nanotax.

5 Aug 2004

ATS receives US $10.7 million in orders from one of the world's largest medical device companies

ATS Automation Tooling Systems has announced it has recently received a total of US $10.7 million (CDN $14.2 million) in orders from one of the world's largest manufacturers of self-use medical diagnostic systems.

5 Aug 2004

Experimental vaccine against ricin

Scientists have developed an experimental vaccine against ricin, a potential biological threat agent, which fully protected mice from aerosol challenge with lethal doses of the toxin.

5 Aug 2004

Spitfire fighter device helps monitor aortic aneurysm

Researchers at the University of Warwick have found a way of using a test devised in the 1930s, and used to gauge the stress on the superchargers in wartime spitfire fighter planes, to model the stress that surgical procedures would put on an aortic aneurysm.

5 Aug 2004

Philadelphia diet drug trial completed

Wyeth has announced that the jury in the case of Rhonda Istnick and Henry Clepper v. Wyeth, et al. rendered its decision, finding in favor of the Company in the case brought by Ms. Istnick, while awarding Mr. Clepper compensatory damages in the amount of $48,000.

29 Jul 2004

Study to investigate carpal tunnel syndrome

Carpal tunnel is a painful progressive condition caused by compression of a key nerve in the wrist. Approximately two out of every 1,000 workers will experience carpal tunnel syndrome every year, leading to significant medical expenditures and lost time from work.

26 Jul 2004

Manufacturing News and Research

Further Reading

Sinovac completes dosing in phase 1 human clinical testing of SARS vaccine

New drug application for exenatide has been accepted for review

Ageing population and technological progress combine to drive European orthopaedic braces and supports market

Call for increased political and financial commitment to the development of preventive and therapeutic AIDS vaccines

High tech implants to aid facial reconstruction

Chiron delays Fluvirin influenza virus vaccine shipments

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Contract for the production of an investigational vaccine based on an H9N2 strain of avian influenza virus

Study on RNAi technology targeting neurodegenerative diseases

Dynamics between disposable and reusable segments affect expansion of disposable drapes and gowns markets

Genentech announces FDA approval of Avastin manufacturing

FDA asks Utah Medical Products to stop manufacturing and distributing medical devices

Total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010

Illinoisans get legislation giving the state more regulatory authority over water bottling plants

Promising new cancer drug, Nanotax

ATS receives US $10.7 million in orders from one of the world's largest medical device companies

Experimental vaccine against ricin

Spitfire fighter device helps monitor aortic aneurysm

Philadelphia diet drug trial completed

Study to investigate carpal tunnel syndrome

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®